CXCR4 and Right ventricular hypertrophy: Interestingly, Gambaryan et al. most recently reported that AMD3100, an antagonist of CXCR4, prevented in part pulmonary hypertension, vascular remodeling and right ventricular hypertrophy induced by chronic hypoxia in mice [27].